mTORC2 promotes type I insulin-like growth factor receptor and insulin receptor activation through the tyrosine kinase activity of mTOR
Yancun Yin(Binzhou Medical University), Yangfu Jiang(Sichuan University)
Cited by 143
Related Papers
Targeting mTOR for cancer therapy
|Journal of Hematology & Oncology|2019|921
Targeting extracellular matrix stiffness and mechanotransducers to improve cancer therapy
|Journal of Hematology & Oncology|2022|455
Bifunctional enzyme ATIC promotes propagation of hepatocellular carcinoma by regulating AMPK-mTOR-S6 K1 signaling
|Cell Communication and Signaling|2017|81
Myricetin Suppresses the Propagation of Hepatocellular Carcinoma via Down-Regulating Expression of YAP
|Cells|2019|79
Gamma synuclein is a novel Twist1 target that promotes TGF-β-induced cancer cell migration and invasion
|Cell Death and Disease|2018|57